Meili Sun

Title: **Innovations of Meili Sun: A Trailblazer in Pharmaceutical Inventions**

Introduction

Meili Sun, an innovative inventor based in Shenzhen, China, has made significant contributions to the field of pharmaceutical compositions. With a total of four patents to his name, his work demonstrates a keen focus on improving medicinal formulations and preparation methods aimed at enhancing patient care and treatment efficiency.

Latest Patents

Meili Sun's most recent patents explore groundbreaking advancements in oral pharmaceutical compositions. His notable invention involves a formulation that combines a pharmaceutically acceptable acidic medicinal auxiliary material, modified for improved efficacy, with dabigatran etexilate or its acceptable salts or aquo-complexes. The invention also encompasses a surface modification method for the auxiliary material, which is crucial in enhancing the overall therapeutic properties of the pharmaceutical composition.

Career Highlights

Sun is a key figure at Shenzhen Pharmacin Co., Ltd., where he applies his expertise in pharmaceutical sciences to drive innovation. His dedication to research and development is reflected in his patent portfolio, which showcases a commitment to advancing the field and improving pharmaceutical solutions.

Collaborations

Throughout his career, Meili Sun has collaborated with talented colleagues such as Yulan Zhao and Lijiang Wang. Their combined efforts contribute to a collaborative environment focused on pushing the boundaries of what is possible within pharmaceutical research and development.

Conclusion

Meili Sun's contributions to the field of pharmaceuticals through his innovative patents exemplify the impact of dedicated inventors in advancing medical science. His work not only enhances our understanding of drug formulation but also paves the way for more effective therapeutic options for patients worldwide.